Value-based care is often discussed in the context of oncology, where care does not come cheap and its associated toxicities—both financial and clinical—can have a substantial impact on patient quality of life. But efficient collaboration among primary care providers, oncologists, and other care team members is crucial to ensure patients with cancer receive the best possible treatment for their specific disease.
Expert presenters and panelists at The American Journal of Managed Care’s Institute for Value-Based Medicine session on September 14, 2023, held in partnership with Zangmeister Cancer Center in Columbus, Ohio, discussed value-based care in the context of primary care and oncology as well as the ways in which providers and practices can work together to improve care for patients with cancer while mitigating financial toxicity.
“As much as we advanced clinically—we have great treatment options for patients, we’re advancing with research and clinical experience, which is wonderful—I think we all are facing a lot of concerns about the other side of things and the actual system itself and how we navigate that. There’s a lot of unknowns and lack of transparency in terms of understanding it,” event cochair Jeanna Knoble, MD, medical oncology and hematology managing partner at the Mark H. Zangmeister Cancer Center, said. Knoble hosted alongside Christine Pfaff, RPh, senior regional director of operations at American Oncology Network.